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Other names: Alpha-PAK; MGC130000; 
MGC130001; P65-PAK; PAK-1; PAKalpha 
Location: 11q13.5 
Local order: centromere - MYO7A - GDPD4 - 
LOC387791 - PAK1 - DFFZp434E1119 - FLJ38894 - 
AQP11. 
Note: PAK1 encodes a serine/threonine specific protein 
kinase that is a member of the PAK branch of the 
STE20 family. PAK1 plays a role in cell survival, 
polarity, and motility, and may have oncogenic 




The alignment of PAK1 mRNA to its genomic sequence. 
Description 
The PAK1 gene contains 14 exons. The sizes of the 
exons 1-14 are 189, 100, 129, 147, 37, 119, 174, 63, 48, 
112, 117, 99, 196, 137, and 86 bps. Exon 2 contains he 
translation initation ATG, and a few additional codons. 
Exon 13 contains the stop codon. Other features of the 
PAK1 gene, such as promoters or enhancer elements, 
have not been described. 
Transcription 
PAK1 expression is particularly high in the brain. 
Other tissues which have reasonably high levels of 
PAK1 expression include spleen and skeletal muscle. 
The mRNA size is 1945 bps. 
Protein 
Description 
PAK1 is a highly conserved serine/threonine protein 
kinase of 545 amino acids and is a member of the PAK
group of the STE20 family of serine/threonine protein 
kinases. Pak1 is active in a monomeric form; the non-
active form is an autoinhibited homodimer. Pak1 
contains a regulatory N-terminal regulatory domain and 
non-classical SH3-binding site for the PIX family of 
proteins (PXP). Pak1 binds to activated forms of the
GTPases Cdc42 and Rac. Pak1 homodimerizes through 




Upon binding to Cdc42 or Rac, Pak1 is activated and 
autophosphorylates. Pak1 has dozens of substrates, 
activating cytoskeletal and transcription pathways that 
enhance cell motility, proliferation, and survival. 
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Expression 
PAK1 is highly expressed in epithelium of tongue and 
larynx and in thyroid gland, expression also found i  
central nervous system (brain). 
Localisation 
Under basal conditions, Pak1 localizes to the cytosol. 
Upon growth factor stimulation, Pak1 is recruited to the 
plasma membrane as well as the nucleus. 
Function 
Cell survival and proliferation 
Homology 
Similar to STE20 in budding yeast and PAK1 in fission 
yeast. Human PAK1 complements both these yeast 
genes. 
Mutations 





There is emerging evidence that the Pak family may 
play a key role in several human malignancies, 
including breast, ovarian, head and neck, colon, 
thyroid, and renal cancer. In human breast cancer, th  
expression level of Pak1 correlates with the tumor 
grade, with higher expression in less differentiated 
ductal carcinomas of the breast (grade III tumors) than 
in grade II and grade I tumors.  
Pak1 overexpression is also associated with tamoxifen 
resistance in breast cancer. In human tumors, Pak1 is  
not itself activated by mutation: rather, Pak1 is  
 
overexpressed by unknown mechanisms. Pak1 may 
also play a role in transformation by Kaposi's sarcoma-
associated herpes virus, which induces Kaposi's 
sarcoma and primary effusion lymphomas. 
Prognosis 
Recently, it has been shown that the level of 
phosphorylated (activated) Pak1 Level in the cytoplasm 
correlates with shorter survival time in patients with 
glioblastoma. As noted above, Pak1 expression may 
also correlate with tamoxifen resistance in breast 
cancer. 
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